Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Satten

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transfusion|April 1, 1994
Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study GroupL R Petersen, G A Satten, R Dodd, et al.
Public Health Reports (Washington, D.C. : 1974)|January 1, 1994
Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalized patients. Centers for Disease Control and PreventionB Schwartländer, R S Janssen, G A Satten, et al.
Genetic Epidemiology|November 24, 2006
Simple methods for assessing haplotype-environment interactions in case-only and case-control studiesL C Kwee, M P Epstein, A K Manatunga, et al.
AIDS (London, England)|September 4, 1998
The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosisJ C Hendriks, G A Satten, E J van Ameijden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San FranciscoW McFarland, M P Busch, T A Kellogg, et al.
Transfusion|September 1, 1994
Direct oral questions to blood donors: the impact on screening for human immunodeficiency virusE S Johnson, L S Doll, G A Satten, et al.
The New England Journal of Medicine|March 27, 1998
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsF J Palella, K M Delaney, A C Moorman, et al.
AIDS (London, England)|June 1, 1996
Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual menJ C Hendriks, G A Satten, I M Longini, et al.
Transfusion|February 1, 1995
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsM P Busch, L L Lee, G A Satten, et al.
The New England Journal of Medicine|December 28, 1995
Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United StatesE M Lackritz, G A Satten, J Aberle-Grasse, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transfusion|April 1, 1994
Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study GroupL R Petersen, G A Satten, R Dodd, et al.
Public Health Reports (Washington, D.C. : 1974)|January 1, 1994
Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalized patients. Centers for Disease Control and PreventionB Schwartländer, R S Janssen, G A Satten, et al.
Genetic Epidemiology|November 24, 2006
Simple methods for assessing haplotype-environment interactions in case-only and case-control studiesL C Kwee, M P Epstein, A K Manatunga, et al.
AIDS (London, England)|September 4, 1998
The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosisJ C Hendriks, G A Satten, E J van Ameijden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San FranciscoW McFarland, M P Busch, T A Kellogg, et al.
Transfusion|September 1, 1994
Direct oral questions to blood donors: the impact on screening for human immunodeficiency virusE S Johnson, L S Doll, G A Satten, et al.
The New England Journal of Medicine|March 27, 1998
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsF J Palella, K M Delaney, A C Moorman, et al.
AIDS (London, England)|June 1, 1996
Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual menJ C Hendriks, G A Satten, I M Longini, et al.
Transfusion|February 1, 1995
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsM P Busch, L L Lee, G A Satten, et al.
The New England Journal of Medicine|December 28, 1995
Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United StatesE M Lackritz, G A Satten, J Aberle-Grasse, et al.
Pageof 4